Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials. (2017)

First Author: Wheeler GM
Attributed to:  Adaptive Clinical Trials funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 28295513

Publication URI:

Type: Journal Article/Review

Volume: 36

Parent Publication: Statistics in medicine

Issue: 16

ISSN: 0277-6715